Optiver Holding’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-459
Closed -$407K 1122
2024
Q3
$407K Sell
459
-1,082
-70% -$973K ﹤0.01% 418
2024
Q2
$1.4M Buy
+1,541
New +$1.23M ﹤0.01% 415
2023
Q4
Sell
-67
Closed -$36K 548
2023
Q3
$36K Buy
+67
New +$34.5K ﹤0.01% 464
2022
Q1
Sell
-116
Closed -$27K 721
2021
Q4
$27K Hold
116
﹤0.01% 521
2021
Q3
$27K Buy
+116
New +$28.6K ﹤0.01% 414

Other funds holding LLY

Optiver Holding's LLY Position: Q4 2024 in Review

Optiver Holding sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 459 shares — an estimated $407K sold.

Optiver Holding first reported a position in LLY in Q3 2021 and held it in 5 quarters. The position peaked at $1.4M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Optiver Holding reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Optiver Holding sold 459 Eli Lilly shares in Q4 2024, an estimated $407K.
  • Optiver Holding first reported a position in Eli Lilly in Q3 2021 and held it in 5 quarters.
  • Optiver Holding's Eli Lilly position peaked at $1.4M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Optiver Holding's 13F filing for Q4 2024, filed 14 Feb 2025.